Profile data is unavailable for this security.
About the company
Cyxone AB is a Sweden-based company, which is primarily focused on specialty pharmaceuticals industry. The Company develops cyclotide drugs for autoimmune and other diseases. The Company's Product T20K is a compound to inhibit pro-inflammatory cytokines such as IL2 and effectively reduce clinical symptoms in an animal model for multiple sclerosis after oral administration. The product T20K, through a pre-clinical program required for clinical studies in multiple sclerosis. The Company's cyclotides technology can be modified, while keeping the core cyclotide drug structure, to introduce a variety of pharmaceutical properties for selected diseases. The Company has acquired the cyclotide patent rights developed by the Medical University of Vienna and the University Medical Center of Freiburg.
- Revenue in SEK (TTM)0.00
- Net income in SEK-21.66m
- Incorporated2015
- Employees1.00
- LocationCyxone ABAdelgatan 21MALMO 211 22SwedenSWE
- Websitehttps://cyxone.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ITonis Inc | 0.00 | -12.64m | 7.41m | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -187.63 | -- | -1,169.36 | -- | -- | -- | -- | -- | -- | -0.8999 | -- | -- | -- | -- | -506.86 | -- | -- | -- |
Evofem Biosciences Inc | 173.11m | 513.47m | 7.72m | 37.00 | 0.0012 | -- | 0.015 | 0.0446 | -5.92 | -5.92 | 0.0826 | -1.36 | 0.935 | 1.72 | 2.73 | 432,756.80 | 295.02 | -211.64 | -- | -- | 63.65 | -- | 315.54 | -1,031.55 | 0.0757 | -2.91 | -- | -- | 8.20 | -- | 164.08 | -- | -10.59 | -- |
Neutra Corp | 188.12k | -5.14m | 7.89m | -- | -- | -- | -- | 41.92 | -0.0002 | -0.0002 | 0.00001 | -0.0003 | 0.2786 | 0.4126 | -- | -- | -758.75 | -682.94 | -- | -- | 46.15 | -- | -2,723.22 | -2,758.85 | 0.0009 | -14.06 | -- | -- | -26.09 | -- | 22.28 | -- | -- | -- |
Cyxone AB | 0.00 | -21.66m | 9.82m | 1.00 | -- | 0.2864 | -- | -- | -0.1732 | -0.1732 | 0.00 | 0.1589 | 0.00 | -- | -- | 0.00 | -50.57 | -66.19 | -57.08 | -72.35 | -- | -- | -- | -- | -- | -- | 0.0042 | -- | -- | -- | 45.87 | -- | -13.31 | -- |
Parenteral Drugs (India) Ltd | 10.97m | -98.60m | 11.16m | -- | -- | -- | -- | 1.02 | -25.61 | -25.61 | 2.85 | -276.37 | 0.0162 | 4.17 | 0.9266 | -- | -14.52 | -17.82 | -- | -- | 35.67 | 40.22 | -898.77 | -191.93 | 0.055 | -0.5192 | -- | -- | -30.17 | -48.70 | 37.26 | -- | -- | -- |
Scorpius Holdings Inc | 105.33m | -348.14m | 11.22m | 82.00 | -- | 0.0132 | -- | 0.1065 | -244.34 | -280.05 | 73.26 | 158.75 | 0.1372 | -- | 26.56 | 118,815.70 | -47.81 | -39.37 | -58.20 | -43.18 | 68.56 | -- | -348.43 | -1,068.21 | 0.2641 | -198.18 | 0.3179 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
Agentix Corp | 0.00 | -10.96m | 11.31m | -- | -- | -- | -- | -- | -0.0253 | -0.0253 | 0.00 | -0.071 | 0.00 | -- | -- | -- | -907.08 | -- | -- | -- | -- | -- | -- | -- | -- | -96.41 | -- | -- | -- | -- | -- | -- | -- | -- |
Hill Inc | 17.34m | -15.43m | 11.54m | -- | -- | 2.08 | -- | 0.6659 | -0.6076 | -0.6076 | 0.6822 | 0.2159 | 0.5046 | 129.23 | 4.56 | -- | -44.92 | -77.46 | -48.92 | -101.03 | 68.14 | 50.14 | -89.01 | -153.93 | 2.97 | -4.23 | 0.7881 | -- | -10.23 | 33.86 | 18.26 | -- | 16.21 | -- |